These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
3. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001 [TBL] [Abstract][Full Text] [Related]
5. Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia. Bertz H; Spyridonidis A; Ihorst G; Engelhardt M; Grüllich C; Wäsch R; Marks R; Finke J Biol Blood Marrow Transplant; 2012 Jun; 18(6):894-902. PubMed ID: 22108569 [TBL] [Abstract][Full Text] [Related]
6. Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia? Ringdén O; Labopin M; Solders M; Beelen D; Arnold R; Ehninger G; Milpied N; Niederwieser D; Hamladji RM; Kyrcz-Krzemien S; Ganser A; Socié G; Stelljes M; Volin L; Craddock C; Mohty M; Transplantation; 2014 Sep; 98(5):569-77. PubMed ID: 24798307 [TBL] [Abstract][Full Text] [Related]
7. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome. Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640 [TBL] [Abstract][Full Text] [Related]
8. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation. Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658 [TBL] [Abstract][Full Text] [Related]
9. Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion. Eefting M; de Wreede LC; Halkes CJ; von dem Borne PA; Kersting S; Marijt EW; Veelken H; Putter H; Schetelig J; Falkenburg JH Haematologica; 2016 Apr; 101(4):506-14. PubMed ID: 26802054 [TBL] [Abstract][Full Text] [Related]
10. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire. Malard F; Milpied N; Blaise D; Chevallier P; Michallet M; Lioure B; Clément L; Hicheri Y; Cordonnier C; Huynh A; Yakoub-Agha I; Peffault de Latour R; Mohty M Biol Blood Marrow Transplant; 2015 Jun; 21(6):1059-67. PubMed ID: 25708220 [TBL] [Abstract][Full Text] [Related]
11. Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation. Bitan M; Ahn KW; Millard HR; Pulsipher MA; Abdel-Azim H; Auletta JJ; Brown V; Chan KW; Diaz MA; Dietz A; Vincent MG; Guilcher G; Hale GA; Hayashi RJ; Keating A; Mehta P; Myers K; Page K; Prestidge T; Shah NN; Smith AR; Woolfrey A; Thiel E; Davies SM; Eapen M Biol Blood Marrow Transplant; 2017 Sep; 23(9):1523-1530. PubMed ID: 28527984 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
13. Transplant for MDS: challenges and emerging strategies. Tamari R; Castro-Malaspina H Best Pract Res Clin Haematol; 2015 Mar; 28(1):43-54. PubMed ID: 25659729 [TBL] [Abstract][Full Text] [Related]
14. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K; Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296 [TBL] [Abstract][Full Text] [Related]
15. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409 [TBL] [Abstract][Full Text] [Related]
16. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC. Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651 [TBL] [Abstract][Full Text] [Related]
17. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study. Chapchap EC; Kerbauy LN; Esteves I; Belucci TR; Rodrigues M; Kerbauy FR; de Souza Santos FP; Ribeiro AAF; Hamerschlak N Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13122. PubMed ID: 31257689 [TBL] [Abstract][Full Text] [Related]
19. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N; Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702 [TBL] [Abstract][Full Text] [Related]
20. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors. Lee KH; Choi SJ; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Yun SC; Joo YD; Lee WS; Kang MJ; Kim H; Park JH; Bae SH; Ryoo HM; Kim MK; Hyun MS Am J Hematol; 2011 May; 86(5):399-405. PubMed ID: 21523798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]